On June 3, 2022 Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, reported that members of the Company’s management team will participate at the following investor conferences in June 2022 (Press release, Altimmune, JUN 3, 2022, View Source [SID1234615525]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies 2022 Global Healthcare Conference in New York, NY
Friday, June 10, 2022
Fireside chat at 10:00 am Eastern Time
JMP Securities Life Sciences Conference in New York, NY
Thursday, June 16, 2022
Fireside chat at 9:00 am Eastern Time
The sessions will be webcast and can be accessed by visiting the Events section of the Altimmune website.